This study aims to evaluated the impact of poly(ε-caprolactone) (PCL) microspheres on the pharmacokinetics and pharmacodynamics (PopPK/PD) of 6-methylcoumarin (6MC). For this, PCL microspheres loaded with 6MC were prepared using the emulsification-evaporation method. Particle size, zeta potential, drug loading, and entrapment efficiency were characterised by dynamic light scattering and UV spectrophotometry. In vitro release and pharmacokinetics in Wistar rats were assessed for free and encapsulated 6MC. Anti-inflammatory activity was evaluated using the carrageenan-induced paw edoema model, with PopPK and PopPK/PD models developed. Microspheres showed diameters between 2.9 and 7.1 µm, zeta potentials of -10 to -15 mV, and drug loading of 0.24 mg/mg. Encapsulation efficiency was 45.5% to 75.9%. PopPK models showed enhanced absorption and distribution, with increased anti-inflammatory potency of encapsulated 6MC. PCL microspheres significantly improved the pharmacokinetic and pharmacodynamic profiles of 6MC, enhancing its therapeutic potential for lipophilic drugs.

Download full-text PDF

Source
http://dx.doi.org/10.1080/02652048.2024.2418606DOI Listing

Publication Analysis

Top Keywords

pcl microspheres
12
6mc pcl
8
drug loading
8
encapsulated 6mc
8
6mc
5
polyε-caprolactone microspheres
4
microspheres population
4
population pharmacokinetic/pharmacodynamic
4
pharmacokinetic/pharmacodynamic model
4
model simple
4

Similar Publications

Aim: Voriconazole (VRZ) is highly effective in treating invasive pulmonary aspergillosis (IPA), in addition to hepatotoxicity. Therefore, the current study focuses on the development and characterization of voriconazole-loaded microspheres (VRZ@PCL MSPs) to augment pulmonary localization and antifungal efficacy.

Methods: VRZ@PCL MSPs were fabricated by using the o/w emulsion method.

View Article and Find Full Text PDF

Background: Injectable augmentation gels are widely used in the treatment of soft tissue. The composition of these gels has to be continuously improved due to the limitations of the currently available formulations.

Aims: This study focuses on the development of an innovative injectable gel designed to address current trends and specific needs within the field.

View Article and Find Full Text PDF

Peripheral nerve injuries (PNI) represent the most common type of nervous system injuries, resulting in 5 million injuries per year. Current gold standard, autografts, still carry several limitations, including the inappropriate type, size, and function matches in grafted nerves, lack of autologous donor sites, neuroma formation, and secondary surgery incisions. Polymeric nerve conduits, also known as nerve guides, can help overcome the aforementioned issues that limit nerve recovery and regeneration by reducing tissue fibrosis, misdirection of regenerating axons, and the inability to maintain long- distance axonal growth.

View Article and Find Full Text PDF

This study aims to evaluated the impact of poly(ε-caprolactone) (PCL) microspheres on the pharmacokinetics and pharmacodynamics (PopPK/PD) of 6-methylcoumarin (6MC). For this, PCL microspheres loaded with 6MC were prepared using the emulsification-evaporation method. Particle size, zeta potential, drug loading, and entrapment efficiency were characterised by dynamic light scattering and UV spectrophotometry.

View Article and Find Full Text PDF
Article Synopsis
  • The delay in healing critical bone defects is mainly caused by low oxygen levels and decreased bone-forming activity.
  • This research developed an injectable hydrogel that releases oxygen and supports bone growth by integrating specific materials like calcium peroxide and nanoparticles.
  • The hydrogel was tested on rats, showing improved bone regeneration and blood vessel formation after 8 weeks, highlighting its potential as a less invasive treatment for serious bone issues.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!